First Nine Months Results 2018
On 31 October DSM reported a very good Q3, contributing to a strong first nine months in 2018.
Commenting on the results, DSM's CEO Feike Sijbesma said "“We are delighted to report another very good quarter and are confident that we can achieve our full year outlook. The continued organic sales and Adjusted EBITDA growth rates in the underlying business position us well for a strong year which would once again exceed our Strategy 2018 targets."
Cargill and Royal DSM to establish joint venture to bring zero-calorie, cost-effective sweeteners to market faster
08 Nov 2018 08:00 CET
DSM informs market on the completion of the sale of DSM Sinochem Pharmaceuticals to Bain Capital
31 Oct 2018 16:00 CET
DSM reports results first nine months 2018
31 Oct 2018 07:00 CET